Conditions: Chronic Hepatitis B
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 144
Healthy volunteers: no

Brief summary:
The purpose of this study is to show that the combination of entecavir and tenofovir, is effective and well tolerated in chronic hepatitis B patients who have failed previous treatment.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Entecavir intervention 2: Tenofovir
Intervention descriptions: intervention 1: Tablets, Oral, 1 mg, once daily, 96 weeks intervention 2: Tablets, Oral, 300 mg, once daily, 96 weeks

Protocol document: